Smith Annika, Lai Belinda, Chow Clara K, Zaman Sarah
Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Department of Dermatology, Westmead Hospital, Westmead, New South Wales, Australia.
Australas J Dermatol. 2025 Sep;66(6):338-343. doi: 10.1111/ajd.14528. Epub 2025 Jun 2.
Patient perspectives on psoriasis as a systemic disease, with its heightened risk of cardiovascular disease (CVD), are unclear. Approaches to cardiovascular risk factor screening and management vary in this cohort. This study aimed to ascertain knowledge, practice and perceptions of patients with respect to psoriasis and CVD, CV risk factor screening and management.
This cross-sectional study consisted of a self-administered questionnaire capturing demographic characteristics, knowledge of the association between psoriasis and CVD, and perspectives on cardiovascular risk factor screening and management. This was distributed to psoriasis patients in public and private clinic settings. The survey data was assessed with the use of descriptive statistics.
A total of 102 patients with psoriasis were surveyed. The majority of respondents were male 52%, (53/102), 46-60 years old 30.4% (31/102), with longstanding psoriasis (> 20 years), 42.2.% (43/102). Most patients nominated a dermatologist in a public hospital setting as the primary clinician responsible for their psoriasis management 71.6% (73/102). A total of 20.6% (21/102) psoriasis patients surveyed indicated knowledge of the association between CVD and psoriasis, and 22.5% (23/102) agreed that psoriasis was associated with worse CVD outcomes compared to the general population. 63.7% (65/102) indicated they had undergone CV risk factor screening in the last year, with most nominating general practitioners (GPs) 38.4% (38/99), followed by cardiologists 14.1% (14/99), then dermatologists 9.1% (9/99), as the clinician who performed this CV RF screening. A total of 68.6% (70/102) responded they did not currently have a treating cardiologist, while 34.3% (35/102) nominated a Cardiologist as their preferred clinician to facilitate CVD risk factor screening/management, 23.5% (24/102) indicated a preference for a multidisciplinary team, 17.6% (18/102) nominated GPs and 6.9% (7/102) nominated the dermatologist.
There is a need for improved patient education regarding the relationship between psoriasis and CVD. Heightened awareness around cardiovascular risk may serve as an impetus for patients to seek relevant cardiovascular risk factor screening, management and pursue healthy lifestyle behaviours.
患者对于银屑病作为一种全身性疾病及其心血管疾病(CVD)风险增加的看法尚不清楚。该队列中对心血管危险因素的筛查和管理方法各不相同。本研究旨在确定患者对银屑病与CVD、心血管危险因素筛查和管理的了解、实践和看法。
这项横断面研究采用自填式问卷,收集人口统计学特征、对银屑病与CVD关联的了解,以及对心血管危险因素筛查和管理的看法。问卷分发给公立和私立诊所的银屑病患者。使用描述性统计分析调查数据。
共对102例银屑病患者进行了调查。大多数受访者为男性,占52%(53/102),年龄在46 - 60岁之间,占30.4%(31/102),患有长期银屑病(>20年),占42.2%(43/102)。大多数患者指定公立医院的皮肤科医生为负责其银屑病治疗的主要临床医生,占71.6%(73/102)。在接受调查的银屑病患者中,共有20.6%(21/102)表示了解CVD与银屑病之间的关联,22.5%(23/102)同意与普通人群相比,银屑病与更差的CVD结局相关。63.7%(65/102)表示他们在过去一年接受了心血管危险因素筛查,大多数指定全科医生(GP),占38.4%(38/99),其次是心脏病专家,占14.1%(14/99),然后是皮肤科医生,占9.1%(9/99),作为进行此项心血管危险因素筛查的临床医生。共有68.6%(70/102)的受访者表示他们目前没有主治心脏病专家,而34.3%(35/102)指定心脏病专家为他们首选的临床医生以促进心血管危险因素筛查/管理,23.5%(24/102)表示倾向于多学科团队,17.6%(18/102)指定全科医生,6.9%(7/102)指定皮肤科医生。
需要加强关于银屑病与CVD之间关系的患者教育。提高对心血管风险的认识可能促使患者寻求相关的心血管危险因素筛查、管理并采取健康的生活方式。